search Created with Sketch.
search Created with Sketch.

Advertisement

AAD Annual Meeting 2019
AAD Annual Meeting 2019
View All Videos

Vitiligo Therapy: Where Can We Go?

February 25, 2019

John E. Harris, MD, PhD

The quality of life impact of vitiligo is significant, says John E. Harris, MD, PhD, who notes that the only FDA-approved treatment for the condition actually works to worsen the underlying pathology. JAK inhibitors show promise, he says, in a review of the latest in vitiligo care and research.

Advertisement

In This Series

View More

Advertisement

Editorially independent coverage supported by SkinAlliance and EltaMD. Practical Dermatology's coverage of the 2019 AAD Annual Meeting is not endorsed by or affiliated with the American Academy of Dermatology (AAD).